Financial News · Live Terminal

Jefferies Initiates Louisiana-Pacific at Buy With $93 Price Target

Louisiana-Pacific (LPX) has an average rating of overweight and mean price target of $91.62, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LPX

Jefferies Initiates FedEx Freight at Buy With $200 Price Target

FedEx Freight Holding (FDXF) has an average rating of overweight and mean price target of $172.57, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$FDXF

JPMorgan Upgrades International Business Machines to Overweight From Neutral, Adjusts PT to $291 From $270

International Business Machines (IBM) has an average rating of overweight and mean price target of $298.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$IBM

Morgan Stanley Upgrades CDW to Overweight From Equalweight, Adjusts PT to $170 From $142

CDW (CDW) has an average rating of overweight and mean price target of $145.11, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$CDW

Piper Sandler Upgrades Synopsys to Overweight From Neutral, Adjusts PT to $550 From $450

Synopsys (SNPS) has an average rating of overweight and mean price target of $569.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SNPS

Craig Hallum Downgrades Apogee Therapeutics to Hold From Buy, $135.11 Price Target

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $122.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.63, Change: $+42.25, Percent Change: +46.75%

Citigroup Downgrades Apogee Therapeutics to Neutral From Buy, Price Target is $135

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $119.07, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.65, Change: $+42.27, Percent Change: +46.76%

Update: Seaport Global Upgrades BWX Technologies to Buy From Neutral, Price Target is $245

(Updates with the analyst's commentary.)Seaport Global upgraded BWX Technologies (BWXT) to buy from neutral, citing the company's acquisition of Precision Components Group after a "strong" fiscal Q1.PCG 2025 revenue was about $125 million and it paid about $200 million for the firm, the brokerage said, citing BWX management.PCG is an authorized nuclear component manufacturer and certified for aerospace and defense quality-management, Seaport said.BWX Technologies has an average rating of overweight and mean price target of $240.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $212.56, Change: $+7.16, Percent Change: +3.49%

$BWXT

Wedbush Downgrades Apogee Therapeutics to Neutral From Outperform, Price Target is $135

Update: KeyBanc Initiates Coverage on SpaceX With Sector Weight Rating

(Updated to include KeyBanc commentary)KeyBanc initiated coverage on SpaceX (SPCX) with sector weight rating, noting that the company possesses significant disruptive growth avenues, but this is reflected in current valuation and risk/reward is balanced.The rocket firm is well positioned to maintain its dominant position in space launch and space-adjacent verticals for the foreseeable future, capitalizing on its competitive head start, analysts led by Michael Leshock wrote.Additionally, Starlink is viewed as a key driver of profitable growth, with improved capabilities (direct-to-cell) and faster speeds to be enabled by Starship and Starlink V3 satellites in H2, the analysts mentioned.SpaceX has an average rating of overweight and mean price target of $254.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $167.79, Change: $-17.22, Percent Change: -9.31%

$SPCX

Mainstreet Equity Price Target Lowered to $225 at ATB; Keeps Outperform Rating

ATB Capital Markets lowered its price target on Mainstreet Equity (MEQ.TO) to $225 from $245 on Monday.Analyst Sairam Srinivas maintained an Outperform rating on shares of the Canadian real estate company."With a targeted mid-market acquisition strategy that offers significant market penetration opportunities, an operating platform that enhances property yields through standardized renovation and cost management, and a strong financial structure that benefits from low-cost CMHC debt and the ability to reinvest operational cash flow into the portfolio, we believe MEQ has all the requisite components of a cash compounding vehicle in a relatively favourable macro environment," Srinivas said in a note to clients.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MEQ.TO

Alamos Gold Price Target Lowered to $61 at TD

TD Securities lowered its price target on Alamos Gold (AGI.TO) to $61 from $78 on Monday.Analyst Steven Green maintained a Buy rating on shares of the Canadian mining company.On June 18, Alamos reduced its Q2 production guidance after saying seismic events damaged infrastructure at its Young-Davidson operation."The update is disappointing and follows a guidance miss in 2025, we believe it is now baked in the stock and Island is now ramping up," Green said in a note."The 19% decline in share price has reduced market cap by over $2.3 billion, which is ~75% of our YD NAV, so we believe this is more than baked in now," Green said.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $43.10, Change: $+1.18, Percent Change: +2.81%

$AGI.TO

Canaccord Genuity Downgrades Apogee Therapeutics to Hold From Buy, Adjusts Price Target to $135.11 From $130

Apogee Therapeutics (APGE) has an average rating of buy and mean price target of $119.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Capital One Initiates Murphy USA at Overweight With $710 Price Target

Murphy USA (MUSA) has an average rating of hold and mean price target of $581.20, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MUSA

MDA Space Price Target Raised to $64 at CIBC

CIBC Capital Markets raised its price target on MDA Space (MDA.TO) to $64 from $57.Analyst Erin Kyle maintained an Outperformer rating on shares of the Canadian space technology solutions and services company. The move comes after MDA announced a deal on Friday to acquire Blue Canyon Technologies for $874 million in cash."In our view, the acquisition is a strong strategic fit, adding a US manufacturing footprint that broadens the reach of MDA's portfolio and meaningfully improves its ability to pursue US defence opportunities," Kyle said in a note to clients."Blue Canyon is a profitable, cash-generating business, the deal is accretive, and is broadly neutral to slightly favourable on valuation multiples," the analyst said. "MDA still trades at a meaningful discount to US space peers, and we see potential for multiple expansion as its US presence grows."(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MDA.TO

Bernstein Trims British Land PT, Keeps Outperform Rating

Bernstein on Monday decreased the price target of real estate company British Land (BLND.L) to 4.90 pounds sterling from 5 pounds, while affirming its outperform rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BLND.L

Oddo BHF Boosts Voestalpine's PT, Maintains Neutral Rating

Oddo BHF on Monday raised its price target for Austrian steel products manufacturer voestalpine (VOE.VI, VAS.F) to 46 euros from 40 euros and affirmed its neutral rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$VAS.F$VOE.VI

Kepler Cheuvreux Cuts Mercedes-Benz PT, Affirms Hold Rating

Kepler Cheuvreux on Monday reduced its price target for German automaker Mercedes-Benz Group (MBG.F) to 48 euros from 57 euros, while maintaining its hold rating.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MBG.F